Trial · NCT01774786
Adverse events480
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 480
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Pertuzumab + Trastuzumab + Chemotherapy | 159 | 385 | 208 |
| other | Anaemia | Blood and lymphatic system disorders | Placebo + Trastuzumab + Chemotherapy | 142 | 388 | 189 |
| other | Leukopenia | Blood and lymphatic system disorders | Pertuzumab + Trastuzumab + Chemotherapy | 80 | 385 | 148 |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo + Trastuzumab + Chemotherapy | 69 | 388 | 113 |
| other | Neutropenia | Blood and lymphatic system disorders | Pertuzumab + Trastuzumab + Chemotherapy | 200 | 385 | 340 |
| other | Neutropenia | Blood and lymphatic system disorders | Placebo + Trastuzumab + Chemotherapy | 202 | 388 | 298 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Pertuzumab + Trastuzumab + Chemotherapy | 61 | 385 | 105 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo + Trastuzumab + Chemotherapy | 73 | 388 | 100 |
| other | Abdominal distension | Gastrointestinal disorders | Pertuzumab + Trastuzumab + Chemotherapy | 25 | 385 | 36 |
| other | Abdominal distension | Gastrointestinal disorders | Placebo + Trastuzumab + Chemotherapy | 19 | 388 | 24 |
| other | Abdominal pain | Gastrointestinal disorders | Pertuzumab + Trastuzumab + Chemotherapy | 44 | 385 | 60 |
| other | Abdominal pain | Gastrointestinal disorders | Placebo + Trastuzumab + Chemotherapy | 51 | 388 | 59 |
| other | Abdominal pain upper | Gastrointestinal disorders | Pertuzumab + Trastuzumab + Chemotherapy | 28 | 385 | 33 |
| other | Abdominal pain upper | Gastrointestinal disorders | Placebo + Trastuzumab + Chemotherapy | 23 | 388 | 25 |
| other | Constipation | Gastrointestinal disorders | Pertuzumab + Trastuzumab + Chemotherapy | 56 | 385 | 64 |
| other | Constipation | Gastrointestinal disorders | Placebo + Trastuzumab + Chemotherapy | 84 | 388 | 107 |
| other | Diarrhoea | Gastrointestinal disorders | Pertuzumab + Trastuzumab + Chemotherapy | 230 | 385 | 351 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo + Trastuzumab + Chemotherapy | 125 | 388 | 173 |
| other | Dyspepsia | Gastrointestinal disorders | Pertuzumab + Trastuzumab + Chemotherapy | 24 | 385 | 27 |
| other | Dyspepsia | Gastrointestinal disorders | Placebo + Trastuzumab + Chemotherapy | 30 | 388 | 40 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01774786/events